ASTRAL- a Clinical Study to Assess the Efficacy and Toxicity of High-dose Chemotherapy

NCT04121507 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Aggressive Non-hodgkin Lymphoma (aNHL)
Lymphoma, B-Cell
Lymphoma, T-Cell

Interventions

DRUG: High dose chemotherapy before allogeneic stem cell transplantation (alloSCT)
PROCEDURE: Bone marrow histology
DIAGNOSTIC_TEST: clinical and laboratory parameters
DIAGNOSTIC_TEST: PET-CT or CT

Sponsor

GWT-TUD GmbH